Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors

In neuroendocrine tumors molecular imaging methods play a key role, either targeting the somatostatin receptor or catecholamine pathways. [18F]SiTATE is a somatostatin receptor-targeting peptide that uses silicon fluoride acceptor (SiFA) radiochemistry, overcoming disadvantages of Gallium-68 labelle...

Full description

Saved in:
Bibliographic Details
Main Authors: Roll, Wolfgang (Author) , Hadjitheodorou, Panayiotis (Author) , Alevroudis, Emmanouil (Author) , Kyrou, Kyriaki (Author) , Adamou, Giorgos (Author) , Fesas, Andreas (Author) , Wängler, Björn (Author) , Wängler, Carmen (Author) , Schirrmacher, Ralf (Author) , Pourkhessalian, Mohammad R. (Author) , Kalogirou, Charalambia (Author) , Tsechelidis, Ioannis (Author) , Vrachimis, Alexis (Author)
Format: Article (Journal)
Language:English
Published: 2025
In: European journal of nuclear medicine and molecular imaging

ISSN:1619-7089
DOI:10.1007/s00259-025-07572-w
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-025-07572-w
Get full text
Author Notes:Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis

MARC

LEADER 00000naa a22000002c 4500
001 1939720192
003 DE-627
005 20251030075929.0
007 cr uuu---uuuuu
008 251030s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00259-025-07572-w  |2 doi 
035 |a (DE-627)1939720192 
035 |a (DE-599)KXP1939720192 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Roll, Wolfgang  |d 1988-  |e VerfasserIn  |0 (DE-588)112590514X  |0 (DE-627)880471840  |0 (DE-576)483614823  |4 aut 
245 1 0 |a Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors  |c Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis 
264 1 |c 2025 
300 |b Illustrationen, Diagramme 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist "18F" in eckigen Klammern geschrieben und hochgestellt 
500 |a Online veröffentlicht: 26. September 2025 
500 |a Gesehen am 30.10.2025 
520 |a In neuroendocrine tumors molecular imaging methods play a key role, either targeting the somatostatin receptor or catecholamine pathways. [18F]SiTATE is a somatostatin receptor-targeting peptide that uses silicon fluoride acceptor (SiFA) radiochemistry, overcoming disadvantages of Gallium-68 labelled DOTA compounds. Here we present the first prospective data of [18F]SiTATE compared to [18F]DOPA-PET in NET patients. 
650 4 |a [18F]DOPA 
650 4 |a [18F]SiTATE 
650 4 |a Neuroendocrine tumor 
700 1 |a Hadjitheodorou, Panayiotis  |e VerfasserIn  |4 aut 
700 1 |a Alevroudis, Emmanouil  |e VerfasserIn  |4 aut 
700 1 |a Kyrou, Kyriaki  |e VerfasserIn  |4 aut 
700 1 |a Adamou, Giorgos  |e VerfasserIn  |4 aut 
700 1 |a Fesas, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Wängler, Björn  |d 1975-  |e VerfasserIn  |0 (DE-588)129702218  |0 (DE-627)477593909  |0 (DE-576)297793888  |4 aut 
700 1 |a Wängler, Carmen  |d 1978-  |e VerfasserIn  |0 (DE-588)133775593  |0 (DE-627)556368177  |0 (DE-576)30009230X  |4 aut 
700 1 |a Schirrmacher, Ralf  |e VerfasserIn  |4 aut 
700 1 |a Pourkhessalian, Mohammad R.  |e VerfasserIn  |4 aut 
700 1 |a Kalogirou, Charalambia  |e VerfasserIn  |4 aut 
700 1 |a Tsechelidis, Ioannis  |e VerfasserIn  |4 aut 
700 1 |a Vrachimis, Alexis  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European journal of nuclear medicine and molecular imaging  |d Heidelberg [u.a.] : Springer-Verl., 2002  |g (2025)  |h Online-Ressource  |w (DE-627)359787258  |w (DE-600)2098375-X  |w (DE-576)110279549  |x 1619-7089  |7 nnas  |a Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors 
773 1 8 |g year:2025  |g extent:8  |a Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors 
856 4 0 |u https://doi.org/10.1007/s00259-025-07572-w  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251030 
993 |a Article 
994 |a 2025 
998 |g 133775593  |a Wängler, Carmen  |m 133775593:Wängler, Carmen  |d 60000  |d 62900  |d 60000  |e 60000PW133775593  |e 62900PW133775593  |e 60000PW133775593  |k 0/60000/  |k 1/60000/62900/  |k 0/60000/  |p 8 
998 |g 129702218  |a Wängler, Björn  |m 129702218:Wängler, Björn  |d 60000  |d 62900  |e 60000PW129702218  |e 62900PW129702218  |k 0/60000/  |k 1/60000/62900/  |p 7 
999 |a KXP-PPN1939720192  |e 4794550111 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors","title_sort":"Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumors"}],"name":{"displayForm":["Wolfgang Roll, Panayiotis Hadjitheodorou, Emmanouil Alevroudis, Kyriaki Kyrou, Giorgos Adamou, Andreas Fesas, Björn Wängler, Carmen Wängler, Ralf Schirrmacher, Mohammad R. Pourkhessalian, Charalambia Kalogirou, Ioannis Tsechelidis, Alexis Vrachimis"]},"person":[{"role":"aut","given":"Wolfgang","display":"Roll, Wolfgang","family":"Roll"},{"role":"aut","given":"Panayiotis","display":"Hadjitheodorou, Panayiotis","family":"Hadjitheodorou"},{"family":"Alevroudis","display":"Alevroudis, Emmanouil","role":"aut","given":"Emmanouil"},{"display":"Kyrou, Kyriaki","given":"Kyriaki","role":"aut","family":"Kyrou"},{"family":"Adamou","display":"Adamou, Giorgos","role":"aut","given":"Giorgos"},{"given":"Andreas","role":"aut","display":"Fesas, Andreas","family":"Fesas"},{"family":"Wängler","given":"Björn","role":"aut","display":"Wängler, Björn"},{"family":"Wängler","display":"Wängler, Carmen","given":"Carmen","role":"aut"},{"given":"Ralf","role":"aut","display":"Schirrmacher, Ralf","family":"Schirrmacher"},{"family":"Pourkhessalian","display":"Pourkhessalian, Mohammad R.","role":"aut","given":"Mohammad R."},{"family":"Kalogirou","display":"Kalogirou, Charalambia","given":"Charalambia","role":"aut"},{"role":"aut","given":"Ioannis","display":"Tsechelidis, Ioannis","family":"Tsechelidis"},{"display":"Vrachimis, Alexis","role":"aut","given":"Alexis","family":"Vrachimis"}],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"recId":"1939720192","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Im Titel ist \"18F\" in eckigen Klammern geschrieben und hochgestellt","Online veröffentlicht: 26. September 2025","Gesehen am 30.10.2025"],"relHost":[{"id":{"zdb":["2098375-X"],"issn":["1619-7089"],"eki":["359787258"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Head to head comparison of (18F)SiTATE versus (18F])DOPA-PET in patients with neuroendocrine tumorsEuropean journal of nuclear medicine and molecular imaging","note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"359787258","origin":[{"dateIssuedKey":"2002","publisher":"Springer-Verl.","dateIssuedDisp":"2002-","publisherPlace":"Heidelberg [u.a.]"}],"pubHistory":["29.2002 -"],"title":[{"title":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title_sort":"European journal of nuclear medicine and molecular imaging"}],"language":["eng"],"part":{"extent":"8","text":"(2025)","year":"2025"}}],"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen, Diagramme"}],"id":{"eki":["1939720192"],"doi":["10.1007/s00259-025-07572-w"]}} 
SRT |a ROLLWOLFGAHEADTOHEAD2025